Global Meningococcal Conjugate Market Growth (Status and Outlook) 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meningococcal Conjugate Market Size 2016-2026

2.1.2 Meningococcal Conjugate Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Meningococcal Conjugate Segment by Type

2.2.1 Menactra

2.2.2 Menactra

2.2.3 NeisVac-C

2.2.4 Nimenrix

2.2.5 Others

2.3 Meningococcal Conjugate Market Size by Type

2.3.1 Global Meningococcal Conjugate Market Size CAGR by Type

2.3.2 Global Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

2.4 Meningococcal Conjugate Segment by End User

2.4.1 Children

2.4.2 Preteens or Teens

2.4.3 Adults

2.5 Meningococcal Conjugate Market Size by End User

2.5.1 Global Meningococcal Conjugate Market Size CAGR by End User

2.5.2 Global Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

3 Meningococcal Conjugate Market Size by Players

3.1 Meningococcal Conjugate Market Size Market Share by Players

3.1.1 Global Meningococcal Conjugate Revenue by Players (2019-2021E)

3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2019-2021E)

3.2 Global Meningococcal Conjugate Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Meningococcal Conjugate by Regions

4.1 Meningococcal Conjugate Market Size by Regions (2016-2021)

4.2 Americas Meningococcal Conjugate Market Size Growth (2016-2021)

4.3 APAC Meningococcal Conjugate Market Size Growth (2016-2021)

4.4 Europe Meningococcal Conjugate Market Size Growth (2016-2021)

4.5 Middle East & Africa Meningococcal Conjugate Market Size Growth (2016-2021)

5 Americas

5.1 Americas Meningococcal Conjugate Market Size by Country (2016-2021)

5.2 Americas Meningococcal Conjugate Market Size by Type (2016-2021)

5.3 Americas Meningococcal Conjugate Market Size by End User (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meningococcal Conjugate Market Size by Region (2016-2021)

6.2 APAC Meningococcal Conjugate Market Size by Type (2016-2021)

6.3 APAC Meningococcal Conjugate Market Size by End User (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Meningococcal Conjugate by Country (2016-2021)

7.2 Europe Meningococcal Conjugate Market Size by Type (2016-2021)

7.3 Europe Meningococcal Conjugate Market Size by End User (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meningococcal Conjugate by Region (2016-2021)

8.2 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021)

8.3 Middle East & Africa Meningococcal Conjugate Market Size by End User (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Meningococcal Conjugate Market Forecast

10.1 Global Meningococcal Conjugate Forecast by Regions (2021-2026)

10.1.1 Global Meningococcal Conjugate Forecast by Regions (2021-2026)

10.1.2 Americas Meningococcal Conjugate Forecast

10.1.3 APAC Meningococcal Conjugate Forecast

10.1.4 Europe Meningococcal Conjugate Forecast

10.1.5 Middle East & Africa Meningococcal Conjugate Forecast

10.2 Americas Meningococcal Conjugate Forecast by Countries (2021-2026)

10.2.1 United States Meningococcal Conjugate Market Forecast

10.2.2 Canada Meningococcal Conjugate Market Forecast

10.2.3 Mexico Meningococcal Conjugate Market Forecast

10.2.4 Brazil Meningococcal Conjugate Market Forecast

10.3 APAC Meningococcal Conjugate Forecast by Region (2021-2026)

10.3.1 China Meningococcal Conjugate Market Forecast

10.3.2 Japan Meningococcal Conjugate Market Forecast

10.3.3 Korea Meningococcal Conjugate Market Forecast

10.3.4 Southeast Asia Meningococcal Conjugate Market Forecast

10.3.5 India Meningococcal Conjugate Market Forecast

10.3.6 Australia Meningococcal Conjugate Market Forecast

10.4 Europe Meningococcal Conjugate Forecast by Country (2021-2026)

10.4.1 Germany Meningococcal Conjugate Market Forecast

10.4.2 France Meningococcal Conjugate Market Forecast

10.4.3 UK Meningococcal Conjugate Market Forecast

10.4.4 Italy Meningococcal Conjugate Market Forecast

10.4.5 Russia Meningococcal Conjugate Market Forecast

10.5 Middle East & Africa Meningococcal Conjugate Forecast by Region (2021-2026)

10.5.1 Egypt Meningococcal Conjugate Market Forecast

10.5.2 South Africa Meningococcal Conjugate Market Forecast

10.5.3 Israel Meningococcal Conjugate Market Forecast

10.5.4 Turkey Meningococcal Conjugate Market Forecast

10.5.5 GCC Countries Meningococcal Conjugate Market Forecast

10.6 Global Meningococcal Conjugate Forecast by Type (2021-2026)

10.7 Global Meningococcal Conjugate Forecast by End User (2021-2026)

11 Key Players Analysis

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Company Information

11.1.2 Sanofi Pasteur Meningococcal Conjugate Product Offered

11.1.3 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Sanofi Pasteur Main Business Overview

11.1.5 Sanofi Pasteur Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Meningococcal Conjugate Product Offered

11.2.3 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Glaxo Smith Kline

11.3.1 Glaxo Smith Kline Company Information

11.3.2 Glaxo Smith Kline Meningococcal Conjugate Product Offered

11.3.3 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Glaxo Smith Kline Main Business Overview

11.3.5 Glaxo Smith Kline Latest Developments

11.4 Hualan Biological Engineering

11.4.1 Hualan Biological Engineering Company Information

11.4.2 Hualan Biological Engineering Meningococcal Conjugate Product Offered

11.4.3 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Hualan Biological Engineering Main Business Overview

11.4.5 Hualan Biological Engineering Latest Developments

11.5 JN International Medical Corporation

11.5.1 JN International Medical Corporation Company Information

11.5.2 JN International Medical Corporation Meningococcal Conjugate Product Offered

11.5.3 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 JN International Medical Corporation Main Business Overview

11.5.5 JN International Medical Corporation Latest Developments

11.6 Baxter International

11.6.1 Baxter International Company Information

11.6.2 Baxter International Meningococcal Conjugate Product Offered

11.6.3 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Baxter International Main Business Overview

11.6.5 Baxter International Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Meningococcal Conjugate Product Offered

11.7.3 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Serum Institute of India

11.8.1 Serum Institute of India Company Information

11.8.2 Serum Institute of India Meningococcal Conjugate Product Offered

11.8.3 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Serum Institute of India Main Business Overview

11.8.5 Serum Institute of India Latest Developments

11.9 Biomed

11.9.1 Biomed Company Information

11.9.2 Biomed Meningococcal Conjugate Product Offered

11.9.3 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Biomed Main Business Overview

11.9.5 Biomed Latest Developments

11.10 Novartis

11.10.1 Novartis Company Information

11.10.2 Novartis Meningococcal Conjugate Product Offered

11.10.3 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Novartis Main Business Overview

11.10.5 Novartis Latest Developments

12 Research Findings and Conclusion

Table 1. Meningococcal Conjugate Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Menactra

Table 3. Major Players of Menveo

Table 4. Major Players of NeisVac-C

Table 5. Major Players of Nimenrix

Table 6. Major Players of Others

Table 7. Meningococcal Conjugate Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 8. Global Meningococcal Conjugate Market Size by Type (2016-2021) & ($ Millions)

Table 9. Global Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

Table 10. Meningococcal Conjugate Market Size CAGR by End User (2016-2021) & ($ Millions)

Table 11. Global Meningococcal Conjugate Market Size by End User (2016-2021) & ($ Millions)

Table 12. Global Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

Table 13. Global Meningococcal Conjugate Revenue by Players (2019-2021E) & ($ Millions)

Table 14. Global Meningococcal Conjugate Revenue Market Share by Players (2019-2021E)

Table 15. Meningococcal Conjugate Key Players Head office and Products Offered

Table 16. Meningococcal Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Meningococcal Conjugate Market Size by Regions 2016-2021 & ($ Millions)

Table 20. Global Meningococcal Conjugate Market Size Market Share by Regions 2016-2021

Table 21. Americas Meningococcal Conjugate Market Size by Country (2016-2021) & ($ Millions)

Table 22. Americas Meningococcal Conjugate Market Size Market Share by Country (2016-2021)

Table 23. Americas Meningococcal Conjugate Market Size by Type (2016-2021) & ($ Millions)

Table 24. Americas Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

Table 25. Americas Meningococcal Conjugate Market Size by End User (2016-2021) & ($ Millions)

Table 26. Americas Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

Table 27. APAC Meningococcal Conjugate Market Size by Region (2016-2021) & ($ Millions)

Table 28. APAC Meningococcal Conjugate Market Size Market Share by Region (2016-2021)

Table 29. APAC Meningococcal Conjugate Market Size by Type (2016-2021) & ($ Millions)

Table 30. APAC Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

Table 31. APAC Meningococcal Conjugate Market Size by End User (2016-2021) & ($ Millions)

Table 32. APAC Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

Table 33. Europe Meningococcal Conjugate Market Size by Country (2016-2021) & ($ Millions)

Table 34. Europe Meningococcal Conjugate Market Size Market Share by Country (2016-2021)

Table 35. Europe Meningococcal Conjugate Market Size by Type (2016-2021) & ($ Millions)

Table 36. Europe Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

Table 37. Europe Meningococcal Conjugate Market Size by End User (2016-2021) & ($ Millions)

Table 38. Europe Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

Table 39. Middle East & Africa Meningococcal Conjugate Market Size by Region (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Region (2016-2021)

Table 41. Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Type (2016-2021)

Table 43. Middle East & Africa Meningococcal Conjugate Market Size by End User (2016-2021) & ($ Millions)

Table 44. Middle East & Africa Meningococcal Conjugate Market Size Market Share by End User (2016-2021)

Table 45. Key and Potential Regions of Meningococcal Conjugate

Table 46. Key Application and Potential Industries of Meningococcal Conjugate

Table 47. Key Challenges of Meningococcal Conjugate

Table 48. Key Trends of Meningococcal Conjugate

Table 49. Global Meningococcal Conjugate Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 50. Global Meningococcal Conjugate Market Size Market Share Forecast by Regions (2021-2026)

Table 51. Global Meningococcal Conjugate Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 52. Global Meningococcal Conjugate Market Size Market Share Forecast by Type (2021-2026)

Table 53. Global Meningococcal Conjugate Market Size Forecast by End User (2021-2026) & ($ Millions)

Table 54. Global Meningococcal Conjugate Market Size Market Share Forecast by End User (2021-2026)

Table 55. Sanofi Pasteur Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 56. Sanofi Pasteur Meningococcal Conjugate Product Offered

Table 57. Sanofi Pasteur Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 58. Sanofi Pasteur Main Business

Table 59. Sanofi Pasteur Latest Developments

Table 60. Pfizer Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 61. Pfizer Meningococcal Conjugate Product Offered

Table 62. Pfizer Main Business

Table 63. Pfizer Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 64. Pfizer Latest Developments

Table 65. Glaxo Smith Kline Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 66. Glaxo Smith Kline Meningococcal Conjugate Product Offered

Table 67. Glaxo Smith Kline Main Business

Table 68. Glaxo Smith Kline Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 69. Glaxo Smith Kline Latest Developments

Table 70. Hualan Biological Engineering Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 71. Hualan Biological Engineering Meningococcal Conjugate Product Offered

Table 72. Hualan Biological Engineering Main Business

Table 73. Hualan Biological Engineering Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 74. Hualan Biological Engineering Latest Developments

Table 75. JN International Medical Corporation Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 76. JN International Medical Corporation Meningococcal Conjugate Product Offered

Table 77. JN International Medical Corporation Main Business

Table 78. JN International Medical Corporation Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 79. JN International Medical Corporation Latest Developments

Table 80. Baxter International Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 81. Baxter International Meningococcal Conjugate Product Offered

Table 82. Baxter International Main Business

Table 83. Baxter International Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 84. Baxter International Latest Developments

Table 85. Merck Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 86. Merck Meningococcal Conjugate Product Offered

Table 87. Merck Main Business

Table 88. Merck Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 89. Merck Latest Developments

Table 90. Serum Institute of India Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 91. Serum Institute of India Meningococcal Conjugate Product Offered

Table 92. Serum Institute of India Main Business

Table 93. Serum Institute of India Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 94. Serum Institute of India Latest Developments

Table 95. Biomed Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 96. Biomed Meningococcal Conjugate Product Offered

Table 97. Biomed Main Business

Table 98. Biomed Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 99. Biomed Latest Developments

Table 100. Novartis Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors

Table 101. Novartis Meningococcal Conjugate Product Offered

Table 102. Novartis Main Business

Table 103. Novartis Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 104. Novartis Latest Developments

List of Figures

Figure 1. Meningococcal Conjugate Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Meningococcal Conjugate Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Meningococcal Conjugate Market Size Market Share by Type in 2020

Figure 7. Meningococcal Conjugate in Children

Figure 8. Global Meningococcal Conjugate Market: Children (2016-2021) & ($ Millions)

Figure 9. Meningococcal Conjugate in Preteens or Teens

Figure 10. Global Meningococcal Conjugate Market: Preteens or Teens (2016-2021) & ($ Millions)

Figure 11. Meningococcal Conjugate in Adults

Figure 12. Global Meningococcal Conjugate Market: Adults (2016-2021) & ($ Millions)

Figure 13. Global Meningococcal Conjugate Market Size Market Share by End User in 2020

Figure 14. Global Meningococcal Conjugate Revenue Market Share by Player in 2020

Figure 15. Global Meningococcal Conjugate Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Meningococcal Conjugate Market Size 2016-2021 ($ Millions)

Figure 17. APAC Meningococcal Conjugate Market Size 2016-2021 ($ Millions)

Figure 18. Europe Meningococcal Conjugate Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Meningococcal Conjugate Market Size 2016-2021 ($ Millions)

Figure 20. Americas Meningococcal Conjugate Market Size Market Share by Country in 2020

Figure 21. Americas Meningococcal Conjugate Market Size Market Share by Type in 2020

Figure 22. Americas Meningococcal Conjugate Market Size Market Share by End User in 2020

Figure 23. United States Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Meningococcal Conjugate Market Size Market Share by Regions in 2020

Figure 27. APAC Meningococcal Conjugate Market Size Market Share by Type in 2020

Figure 28. APAC Meningococcal Conjugate Market Size Market Share by End User in 2020

Figure 29. China Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Meningococcal Conjugate Market Size Market Share by Country in 2020

Figure 36. Europe Meningococcal Conjugate Market Size Market Share by Type in 2020

Figure 37. Europe Meningococcal Conjugate Market Size Market Share by End User in 2020

Figure 38. Germany Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Meningococcal Conjugate Market Size Market Share by End User in 2020

Figure 46. Egypt Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Meningococcal Conjugate Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 52. APAC Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 53. Europe Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 55. United States Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 56. Canada Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 59. China Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 60. Japan Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 61. Korea Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 63. India Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 64. Australia Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 65. Germany Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 66. France Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 67. UK Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 68. Italy Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 69. Russia Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 70. Spain Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 73. Israel Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Meningococcal Conjugate Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Meningococcal Conjugate Market Size 2021-2026 ($ Millions)